The Probiotic Enterococcus Lactis SF68 as a Potential Food Fermentation Microorganism for Safe Food Production
Journal article, 2024

Due to the reports describing virulent and multidrug resistant enterococci, their use has become a topic of controversy despite most of them being safe and commonly used in traditionally fermented foods worldwide. We have characterized Enterococcus lactis SF68, a probiotic strain approved by the European Food Safety Authority (EFSA) for use in food and feed, and find that it has a remarkable potential in food fermentations. Genome analysis revealed the potential of SF68 to metabolize a multitude of carbohydrates, including lactose and sucrose, which was substantiated experimentally. Bacteriocin biosynthesis clusters were identified and SF68 was found to display a strong inhibitory effect against Listeria monocytogenes. Fermentation-wise, E. lactis SF68 was remarkably like Lactococcus lactis and displayed a clear mixed-acid shift on slowly fermented sugars. SF68 could produce the butter aroma compounds, acetoin and diacetyl, the production of which was enhanced under aerated conditions in a strain deficient in lactate dehydrogenase activity. Overall, E. lactis SF68 was found to be versatile, with a broad carbohydrate utilization capacity, a capacity for producing bacteriocins, and an ability to grow at elevated temperatures. This is key to eliminating pathogenic and spoilage microorganisms that are frequently associated with fermented foods.

metabolic flux

sugar fermentation

genomic analysis

cluster of orthologous groups

Enterococcus lactisSF68

Author

Belay Tilahun Tadesse

Technical University of Denmark (DTU)

Novo Nordisk Foundation

Liuyan Gu

Aarhus University

C. Solem

Technical University of Denmark (DTU)

Ivan Mijakovic

Novo Nordisk Foundation

Chalmers, Life Sciences, Systems and Synthetic Biology

C. Jers

Novo Nordisk Foundation

Journal of Agricultural and Food Chemistry

0021-8561 (ISSN) 1520-5118 (eISSN)

Vol. 72 32 18089-18099

Subject Categories

Food Science

DOI

10.1021/acs.jafc.4c03644

PubMed

39102436

More information

Latest update

8/24/2024